ImmunitoAI is a TechBio company developing therapeutic antibody candidates with its proprietary AbInitio™ AI platform
ImmunitoAI is a TechBio company developing therapeutic antibody candidates with its proprietary AbInitio™ AI platform. It designs antibodies for defined protein targets and desired drug characteristics, including potency, safety, stability, and format, and validates candidates using in-house biological methods.